⌘K
Loading ticker…
LanzaTech Global, Inc. Common Stock · Healthcare · Chemicals
As of 2026-06-26, LanzaTech Global, Inc. Common Stock (LNZA) has a 3-month relative strength percentile of 3 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 28. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 16.7%, relative volume 3.50×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
LNZA is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -48.8% / -56.4%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
LNZA is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $676K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $676K |
| VXFVanguard Extended Market ETF | 0.00% | $644K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LNZA Jan avg: -19.15% median: -13.42% win: 0% σ: 10.48% n: 3 2023-02-13 → 2026-05-29 | LNZA Feb avg: -26.50% median: -27.32% win: 0% σ: 8.68% n: 4 2023-02-13 → 2026-05-29 | LNZA Mar avg: -0.88% median: -10.31% win: 25% σ: 65.03% n: 4 2023-02-13 → 2026-05-29 | LNZA Apr avg: 3.52% median: -5.11% win: 50% σ: 36.22% n: 4 2023-02-13 → 2026-05-29 | LNZA May avg: -12.98% median: 0.37% win: 50% σ: 44.38% n: 4 2023-02-13 → 2026-05-29 | LNZA Jun avg: 32.74% median: -3.90% win: 33% σ: 87.23% n: 3 2023-02-13 → 2026-05-29 (current) | LNZA Jul avg: 17.35% median: -2.16% win: 33% σ: 36.39% n: 3 2023-02-13 → 2026-05-29 | LNZA Aug avg: -22.18% median: -17.68% win: 33% σ: 26.88% n: 3 2023-02-13 → 2026-05-29 | LNZA Sep avg: 4.85% median: 15.83% win: 67% σ: 30.35% n: 3 2023-02-13 → 2026-05-29 | LNZA Oct avg: -16.14% median: -12.28% win: 0% σ: 7.36% n: 3 2023-02-13 → 2026-05-29 | LNZA Nov avg: -13.31% median: -26.63% win: 33% σ: 29.46% n: 3 2023-02-13 → 2026-05-29 | LNZA Dec avg: 8.58% median: 10.48% win: 67% σ: 11.12% n: 3 2023-02-13 → 2026-05-29 |